Wenbo Zou

Chinese PLA General Hospital

Papers

2

Total Citations

15

H-Index

2

About

Dr. Wenbo Zou is a pioneering hepatobiliary and pancreatic surgeon whose work is redefining the boundaries of minimally invasive oncology. His primary research focuses on advanced robotic techniques for complex hepatobiliary malignancies, particularly hilar cholangiocarcinoma and pancreatic tumors. Dr. Zou’s major contributions include demonstrating the safety and efficacy of robotic radical antegrade modular pancreatosplenectomy (RAMPS), with a landmark 2023 propensity score-matched study (11 citations) showing comparable short- and long-term outcomes to open surgery—a critical step toward broader adoption of robotic approaches. He is also renowned for developing the innovative "Robotic Taj Mahal Hepatectomy," a technically demanding procedure for Bismuth Type IVa hilar cholangiocarcinoma (4 citations), which combines radical resection of segments 4b, 5, and 1 with bile duct reconstruction. This work, performed on a 32-year-old patient, showcases his ability to push the limits of robotic surgery for the most challenging biliary tumors. With a growing citation impact, Dr. Zou’s research is instrumental in establishing robotic platforms as viable alternatives to open surgery, offering patients reduced morbidity without compromising oncologic outcomes. His achievements position him as a rising leader in the field of minimally invasive hepatobiliary surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
15
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Short- and long-term outcomes of robotic versus open radical antegrade modular pancreatosplenectomy: a retrospective propensity score-matched cohort study
11 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Chinese PLA General Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago